Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142371 |
| CAS No | NA |
| Mol.F. | C11H10FN5O4 |
| Mol.Wt. | 295.23 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142372 |
| CAS No | NA |
| Mol.F. | C5H10N4O4 |
| Mol.Wt. | 190.16 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142373 |
| CAS No | NA |
| Mol.F. | C9H12N2O2 |
| Mol.Wt. | 180.21 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142374 |
| CAS No | NA |
| Mol.F. | C20H25N3O |
| Mol.Wt. | 323 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142375 |
| CAS No | NA |
| Mol.F. | C15H14N2O |
| Mol.Wt. | 238 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142376 |
| CAS No | NA |
| Mol.F. | C23H36N8O6S |
| Mol.Wt. | 552.65 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142377 |
| CAS No | NA |
| Mol.F. | C22H33N5O6S |
| Mol.Wt. | 495.6 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142378 |
| CAS No | NA |
| Mol.F. | C9H16N2O3 |
| Mol.Wt. | 200.24 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142379 |
| CAS No | NA |
| Mol.F. | C23H34N6O7S |
| Mol.Wt. | 538.62 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142380 |
| CAS No | NA |
| Mol.F. | C7H12N2O3 |
| Mol.Wt. | 172.18 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142381 |
| CAS No | NA |
| Mol.F. | C16H24N6O5S |
| Mol.Wt. | 412.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142382 |
| CAS No | NA |
| Mol.F. | C33H45N9O9S2 |
| Mol.Wt. | 775.9 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142383 |
| CAS No | NA |
| Mol.F. | C9H16N2O3 |
| Mol.Wt. | 200.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142384 |
| CAS No | NA |
| Mol.F. | C25H39N7O6S |
| Mol.Wt. | 565.69 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142385 |
| CAS No | NA |
| Mol.F. | C10H12N2O4S |
| Mol.Wt. | 256.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142386 |
| CAS No | NA |
| Mol.F. | C13H18N2O5S |
| Mol.Wt. | 314.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |